|Sample-dependent, check data in validation data gallery|
The immunogen of 60214-1-Ig is P21 Fusion Protein expressed in E. coli.
|Host / Isotype||Mouse / IgG2b|
|Immunogen||P21 fusion protein Ag0308|
|Full Name||cyclin-dependent kinase inhibitor 1A (p21, Cip1)|
|Calculated molecular weight||21 kDa|
|GenBank accession number||BC000312|
|Gene ID (NCBI)||1026|
|Purification Method||Protein A purification|
|Storage Buffer||PBS with 0.02% sodium azide and 50% glycerol pH 7.3.|
|Storage Conditions||Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. 20ul sizes contain 0.1% BSA.|
CDKN1A (p21, CIP1, WAF1), a cyclin-dependent kinase inhibitor, is necessary for proper control of the cell cycle and premature senescence. P21 is a cyclin-dependent kinase (CDK) inhibitor that suppresses proliferation by inhibiting CDK2 and CDK1 activity at the G1/S and G2/M transitions. P21 is a major mediator of p53 to induce cell cycle arrest in G1. p21 can interact with proliferating cell nuclear antigen (PCNA), and plays a regulatory role in S phase DNA replication and DNA damage repair. P21 was reported to be specifically cleaved by CASP3-like caspases, which thus leads to a dramatic activation of CDK2, and may be instrumental in the execution of apoptosis following caspase activation. Overexpression of p21 decreases the expression levels of cell cycle progression genes and upregulates senescence-inducing genes.
MiRNA-20a-5p promotes the growth of triple-negative breast cancer cells through targeting RUNX3.
NFIB promotes cell survival by directly suppressing p21 transcription in p53-mutated triple-negative breast cancer.
Inhibition of cell proliferation by Tas of foamy viruses through cell cycle arrest or apoptosis underlines the different mechanisms of virus-host interactions.
Aging (Albany NY)
Transgenic mice overexpressing glia maturation factor-β, an oxidative stress inducible gene, show premature aging due to Zmpste24 down-regulation.
J Biol Chem
RNA binding protein RBM28 can translocate from the nucleolus to the nucleoplasm to inhibit the transcriptional activity of p53.
Therapeutic Potential of CUDC-907 (Fimepinostat) for Hepatocarcinoma Treatment Revealed by Tumor Spheroids-Based Drug Screening
The reviews below have been submitted by verified Proteintech customers who received an incentive forproviding their feedback.
Ying (Verified Customer) (02-02-2021)
it is very good antibody.
Chunxia (Verified Customer) (02-02-2021)